TY - CHAP
T1 - Comorbidity in Bipolar Disorder
T2 - A Focus on Addiction and Anxiety Disorders
AU - Frye, Mark A.
AU - Perugi, Giulio
PY - 2010/8/13
Y1 - 2010/8/13
KW - Ads, associated with multiple indices of poor outcome in BPD
KW - Anxiety disorders (ADs), most prevalent psychiatric comorbidity amongst patients with Bipolar Disorder (BPD)
KW - BPD comorbidity with substance use disorders and AD - challenging for diagnosis and treatment
KW - Bipolar affective disorder, illness with substantial morbidity and mortality - episodic recurrence of mania/hypomania and major depression
KW - Bipolar disorder comorbidity - focus on addiction and anxiety disorders
KW - Bipolar disorder course of illness - and nicotine dependence
KW - Comorbid alcoholism and bipolar course of illness
KW - Global Assessment of Functioning (GAF) score
KW - National Epidemiological Survey on Alcohol and Related Conditions (NESARC)
KW - Three pharmacotherapies, approved by US FDA - for smoking cessation and nicotine replacement systems
UR - http://www.scopus.com/inward/record.url?scp=84885984398&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84885984398&partnerID=8YFLogxK
U2 - 10.1002/9780470661277.ch4
DO - 10.1002/9780470661277.ch4
M3 - Chapter
AN - SCOPUS:84885984398
SN - 9780470721988
SP - 31
EP - 43
BT - Bipolar Disorder
PB - John Wiley and Sons
ER -